VIVUS Return on Investment 2006-2020 | VVUS

Current and historical return on investment (ROI) values for VIVUS (VVUS) over the last 10 years.
VIVUS ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2020-03-31 $-0.01B $-0.02B -138.46%
2019-12-31 $-0.01B $-0.01B -15.28%
2019-09-30 $-0.01B $-0.00B -3.62%
2019-06-30 $-0.00B $0.06B -1.95%
2019-03-31 $-0.01B $0.25B -1.94%
2018-12-31 $-0.00B $0.25B -1.20%
2018-09-30 $-0.01B $0.26B -2.89%
2018-06-30 $-0.01B $0.27B -2.15%
2018-03-31 $-0.01B $0.22B -3.15%
2017-12-31 $0.00B $0.22B 0.86%
2017-09-30 $0.07B $0.23B 28.87%
2017-06-30 $0.07B $0.23B 28.63%
2017-03-31 $0.07B $0.25B 30.21%
2016-12-31 $0.06B $0.25B 26.38%
2016-09-30 $-0.01B $0.19B -7.06%
2016-06-30 $-0.02B $0.19B -10.18%
2016-03-31 $-0.06B $0.20B -26.61%
2015-12-31 $-0.06B $0.21B -25.05%
2015-09-30 $-0.07B $0.22B -27.86%
2015-06-30 $-0.07B $0.24B -25.46%
2015-03-31 $-0.05B $0.29B -15.74%
2014-12-31 $-0.05B $0.30B -15.19%
2014-09-30 $-0.04B $0.32B -12.15%
2014-06-30 $-0.08B $0.34B -21.08%
2014-03-31 $-0.11B $0.36B -29.50%
2013-12-31 $-0.16B $0.37B -55.36%
2013-09-30 $-0.20B $0.36B -107.16%
2013-06-30 $-0.20B $0.39B -206.65%
2013-03-31 $-0.18B inf%
2012-12-31 $-0.14B inf%
2012-09-30 $-0.10B inf%
2012-06-30 $-0.06B inf%
2012-03-31 $-0.06B inf%
2011-12-31 $-0.05B inf%
2011-09-30 $-0.05B inf%
2011-06-30 $-0.06B -149.33%
2011-03-31 $-0.06B -75.00%
2010-12-31 $-0.07B -50.88%
2010-09-30 $-0.07B $0.15B -38.71%
2010-06-30 $-0.07B $0.17B -37.34%
2010-03-31 $-0.07B $0.19B -35.48%
2009-12-31 $-0.06B $0.20B -32.95%
2009-09-30 $-0.04B $0.22B -27.22%
2009-06-30 $-0.02B $0.13B -13.67%
2009-03-31 $-0.00B $0.14B -2.40%
2008-12-31 $-0.01B $0.14B -4.77%
2008-09-30 $0.01B $0.14B 9.36%
2008-06-30 $0.01B $0.08B 14.34%
2008-03-31 $-0.00B $0.06B -1.78%
2007-12-31 $-0.00B $0.07B -1.82%
2007-09-30 $-0.01B $0.05B -21.82%
2007-06-30 $-0.02B $0.05B -44.22%
2007-03-31 $-0.02B $0.05B -45.16%
2006-12-31 $-0.02B $0.07B -54.66%
2006-09-30 $-0.02B $0.03B -68.75%
2006-06-30 $-0.02B $0.04B -68.22%
2006-03-31 $-0.03B $0.03B -76.34%
2005-12-31 $-0.03B $0.03B -67.57%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.010B $0.070B
VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead investigational product in clinical development, Qnexa(TM), is expected to complete Phase 3 clinical trials for the treatment of obesity in 2009. Qnexa is also in Phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in Phase 3 development with avanafil, its PDE5 inhibitor drug candidate, and in Phase 2 development of Luramist(TM), its drug candidate for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE(R) (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $148.038B 16.30
Bristol Myers Squibb (BMY) United States $131.485B 10.98
Gilead Sciences (GILD) United States $93.714B 12.15
CSL (CSLLY) Australia $88.578B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.590B 52.66
Regeneron Pharmaceuticals (REGN) United States $70.481B 27.17
Illumina (ILMN) United States $54.772B 56.28
Biogen (BIIB) United States $45.480B 7.78
Seattle Genetics (SGEN) United States $31.361B 0.00
Moderna (MRNA) United States $24.118B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.107B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.953B 10.29
Incyte (INCY) United States $23.448B 0.00
Genmab (GMAB) Denmark $23.233B 19.13
BioMarin Pharmaceutical (BMRN) United States $22.932B 207.88
Genmab (GNMSF) Denmark $21.757B 64.60
Alnylam Pharmaceuticals (ALNY) United States $18.345B 0.00
BeiGene (BGNE) Cayman Islands $15.540B 0.00
BioNTech SE (BNTX) Germany $14.845B 0.00
Exact Sciences (EXAS) United States $13.905B 0.00
Sarepta Therapeutics (SRPT) United States $13.255B 0.00
Galapagos (GLPG) Belgium $13.120B 38.59
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
ARGENX SE-ADR (ARGX) Netherlands $11.899B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.065B 27.23
Bio-Techne Corp (TECH) United States $10.602B 70.04
QIAGEN (QGEN) Netherlands $10.146B 29.50
Immunomedics (IMMU) United States $9.767B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.739B 0.00
Guardant Health (GH) United States $8.278B 0.00
Exelixis (EXEL) United States $7.415B 26.00
SWEDISH ORP BIO (BIOVF) Sweden $6.944B 17.28
Repligen (RGEN) United States $6.730B 118.05
Ascendis Pharma (ASND) Denmark $6.718B 0.00
Adaptive Biotechnologies (ADPT) United States $6.159B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.826B 125.36
Novavax (NVAX) United States $5.581B 0.00
Vir Biotechnology (VIR) United States $5.565B 0.00
Acceleron Pharma (XLRN) United States $5.419B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.246B 0.00
Zai Lab (ZLAB) China $5.199B 0.00
Reata Pharmaceuticals (RETA) United States $5.189B 0.00
Mirati Therapeutics (MRTX) United States $5.055B 0.00
Emergent Biosolutions (EBS) United States $4.953B 32.47
MyoKardia (MYOK) United States $4.347B 0.00
MorphoSys AG (MOR) Germany $4.340B 33.66
China Biologic Products (CBPO) China $4.266B 23.72
Blueprint Medicines (BPMC) United States $4.247B 0.00
Global Blood Therapeutics (GBT) United States $4.226B 0.00
Amicus Therapeutics (FOLD) United States $4.079B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.959B 0.00
NeoGenomics (NEO) United States $3.825B 279.31
Halozyme Therapeutics (HALO) United States $3.802B 0.00
Bluebird Bio (BLUE) United States $3.682B 0.00
Inovio Pharmaceuticals (INO) United States $3.679B 0.00
Arena Pharmaceuticals (ARNA) United States $3.310B 0.00
Alkermes (ALKS) Ireland $3.181B 62.63
Deciphera Pharmaceuticals (DCPH) United States $3.057B 0.00
Denali Therapeutics (DNLI) United States $2.833B 0.00
Insmed (INSM) United States $2.826B 0.00
Fate Therapeutics (FATE) United States $2.824B 0.00
Amarin (AMRN) Ireland $2.560B 0.00
PHARMA MAR SA (PHMMF) Spain $2.390B 0.00
Twist Bioscience (TWST) United States $2.304B 0.00
Viela Bio (VIE) United States $2.162B 0.00
UniQure (QURE) Netherlands $2.112B 0.00
Principia Biopharma (PRNB) United States $1.947B 0.00
Editas Medicine (EDIT) United States $1.905B 0.00
Alector (ALEC) United States $1.901B 0.00
Eidos Therapeutics (EIDX) United States $1.881B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.877B 0.00
Ligand Pharmaceuticals (LGND) United States $1.801B 70.13
Forma Therapeutics Holdings (FMTX) United States $1.729B 0.00
Adverum Biotechnologies (ADVM) United States $1.697B 0.00
I-Mab (IMAB) China $1.638B 0.00
Sorrento Therapeutics (SRNE) United States $1.625B 0.00
Intra-Cellular Therapies (ITCI) United States $1.623B 0.00
Zymeworks (ZYME) Canada $1.598B 0.00
Beam Therapeutics (BEAM) United States $1.574B 0.00
Cytokineticsorporated (CYTK) United States $1.553B 0.00
Sangamo Therapeutics (SGMO) United States $1.534B 0.00
Epizyme (EPZM) United States $1.533B 0.00
Mesoblast (MESO) Australia $1.526B 0.00
Mersana Therapeutics (MRSN) United States $1.512B 0.00
Zealand Pharma (ZEAL) Denmark $1.454B 0.00
Revance Therapeutics (RVNC) United States $1.446B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.445B 0.00
REGENXBIO (RGNX) United States $1.429B 0.00
NantKwest (NK) United States $1.388B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
Akcea Therapeutics (AKCA) United States $1.343B 0.00
Arvinas (ARVN) United States $1.340B 0.00
NGM Biopharmaceuticals (NGM) United States $1.314B 0.00
Coherus BioSciences (CHRS) United States $1.267B 8.84
Intellia Therapeutics (NTLA) United States $1.262B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.211B 0.00
Arcus Biosciences (RCUS) United States $1.173B 0.00
Compugen (CGEN) Israel $1.114B 0.00
Athenex (ATNX) United States $1.054B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.988B 0.00
Alcobra (ARCT) United States $0.967B 0.00
VBI Vaccines (VBIV) United States $0.939B 0.00
Retrophin (RTRX) United States $0.869B 0.00
Myriad Genetics (MYGN) United States $0.853B 44.00
Heska (HSKA) United States $0.847B 0.00
Dynavax Technologies (DVAX) United States $0.846B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.825B 0.00
Pharming Group (PHGUF) Netherlands $0.814B 21.67
Morphic Holding (MORF) United States $0.782B 0.00
Castle Biosciences (CSTL) United States $0.755B 0.00
Intrexon (PGEN) United States $0.744B 0.00
Cellectis S.A (CLLS) France $0.738B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.715B 0.00
Frequency Therapeutics (FREQ) United States $0.712B 0.00
Codexis (CDXS) United States $0.702B 0.00
Vericel (VCEL) United States $0.701B 129.50
ZIOPHARM Oncology Inc (ZIOP) United States $0.696B 0.00
Kadmon Holdings (KDMN) United States $0.687B 0.00
Agenus (AGEN) United States $0.656B 0.00
Cue Biopharma (CUE) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Autolus Therapeutics (AUTL) United Kingdom $0.640B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.632B 5.42
AnaptysBio (ANAB) United States $0.615B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.580B 0.00
Kala Pharmaceuticals (KALA) United States $0.572B 0.00
Athersys (ATHX) United States $0.570B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.556B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.553B 0.00
Cel-Sci (CVM) United States $0.547B 0.00
Syros Pharmaceuticals (SYRS) United States $0.545B 0.00
Clovis Oncology (CLVS) United States $0.515B 0.00
NextCure (NXTC) United States $0.500B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.496B 0.00
UROGEN PHARMA (URGN) United States $0.494B 0.00
Anika Therapeutics (ANIK) United States $0.494B 15.88
AC Immune SA (ACIU) Switzerland $0.493B 0.00
Scholar Rock Holding (SRRK) United States $0.490B 0.00
Prothena (PRTA) Ireland $0.482B 0.00
Protagonist Therapeutics (PTGX) United States $0.480B 0.00
DBV Technologies S.A (DBVT) France $0.472B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.466B 0.00
MeiraGTx Holdings (MGTX) United States $0.453B 0.00
Merus (MRUS) Netherlands $0.448B 0.00
Geron (GERN) United States $0.435B 0.00
Precision BioSciences (DTIL) United States $0.427B 0.00
BioDelivery Sciences (BDSI) United States $0.417B 21.90
Puma Biotechnology (PBYI) United States $0.403B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.401B 0.00
Seres Therapeutics (MCRB) United States $0.399B 0.00
MannKind (MNKD) United States $0.386B 0.00
CytomX Therapeutics (CTMX) United States $0.382B 0.00
Avid Bioservices (CDMO) United States $0.380B 0.00
Kamada (KMDA) Israel $0.380B 15.81
Albireo Pharma (ALBO) United States $0.379B 0.00
OSMOTICA PHARM (OSMT) United States $0.361B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
Affimed (AFMD) Germany $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.326B 6.33
PDL BioPharma (PDLI) United States $0.322B 283.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
ChromaDex (CDXC) United States $0.307B 0.00
Prometic Life Sciences (LMNL) Canada $0.301B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.301B 0.00
Cellular Biomedicine (CBMG) United States $0.295B 0.00
Menlo Therapeutics (MNLO) United States $0.283B 0.00
Abeona Therapeutics (ABEO) United States $0.280B 0.00
Spero Therapeutics (SPRO) United States $0.280B 0.00
Celldex Therapeutics (CLDX) United States $0.280B 0.00
Pfenex (PFNX) United States $0.274B 0.00
IBio (IBIO) United States $0.270B 0.00
Gritstone Oncology (GRTS) United States $0.264B 0.00
Northwest Biotherapeutics (NWBO) United States $0.259B 0.00
ADMA Biologics Inc (ADMA) United States $0.248B 0.00
IVERIC Bio (ISEE) United States $0.247B 0.00
Dyadic (DYAI) United States $0.246B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.242B 0.00
Five Prime Therapeutics (FPRX) United States $0.238B 0.00
Selecta Biosciences (SELB) United States $0.236B 0.00
Fortress Biotech (FBIO) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.236B 0.00
Verastem (VSTM) United States $0.236B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Pluristem Therapeutics (PSTI) Israel $0.220B 0.00
Aduro Biotech (ADRO) United States $0.215B 0.00
Aptinyx (APTX) United States $0.213B 0.00
XOMA (XOMA) United States $0.213B 0.00
Liquidia Technologies (LQDA) United States $0.211B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
Sutro Biopharma (STRO) United States $0.203B 0.00
Strongbridge Biopharma (SBBP) United States $0.199B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.198B 2.98
Exicure (XCUR) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
Bellus Health (BLU) Canada $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.181B 0.00
Theratechnologies (THTX) Canada $0.175B 0.00
Trevena (TRVN) United States $0.174B 0.00
Aytu Bioscience (AYTU) United States $0.162B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
Cyclerion Therapeutics (CYCN) United States $0.159B 0.00
Applied Genetic Technologies (AGTC) United States $0.157B 0.00
Kindred Biosciences (KIN) United States $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
Biofrontera AG (BFRA) Germany $0.149B 0.00
TELA Bio (TELA) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
VolitionRX (VNRX) United States $0.134B 0.00
Lumos Pharma (LUMO) United States $0.134B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.132B 0.00
Enzo Biochem (ENZ) United States $0.128B 0.00
Arbutus Biopharma (ABUS) United States $0.128B 0.00
Oncobiologics (OTLK) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.125B 0.00
Palatin Technologies (PTN) United States $0.121B 3.12
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Celsion (CLSN) United States $0.117B 0.00
AIT Therapeutics (XAIR) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.116B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.111B 0.00
Eton Pharmaceuticals (ETON) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.102B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
Cardiff Oncology (CRDF) United States $0.095B 0.00
Cocrystal Pharma (COCP) United States $0.095B 0.00
DiaMedica Therapeutics (DMAC) United States $0.095B 0.00
Unum Therapeutics (UMRX) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.088B 0.00
Organovo Holdings (ONVO) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
Synlogic (SYBX) United States $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.065B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Signal Genetics (MGEN) United States $0.051B 0.00
Curis (CRIS) United States $0.046B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.033B 0.00
Spherix (AIKI) United States $0.032B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.032B 0.00
OvaScience (MLND) United States $0.032B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
BioPharmX (TMBR) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
IMMURON (IMRN) Australia $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.021B 0.00
BioCardia (BCDA) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00